Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
29 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/artbio-announces-132-million-series-b-financing-to-advance-pipeline-of-alpha-radioligand-therapies-and-expand-manufacturing-and-supply-chain-infrastructure-302515367.html
04 Dec 2024
// BUSINESSWIRE
14 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/artbio-to-enter-into-licensing-and-research-partnership-with-3b-pharmaceuticals-to-advance-a-first-in-class-alpha-radioligand-therapy-for-solid-tumors-302303411.html
13 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/artbio-to-enter-into-licensing-and-research-partnership-with-3b-pharmaceuticals-to-advance-a-first-in-class-alpha-radioligand-therapy-for-solid-tumors-302303411.html
14 May 2024
// BUSINESSWIRE
https://www.businesswire.com/news/home/20240514522695/en/FogPharma-and-ARTBIO-Announce-Collaboration-to-Co-Develop-Multiple-Helicon%E2%84%A2-Enabled-Alpha-Particle-Radioligand-Therapies-for-the-Treatment-of-Cancer
14 May 2024
// BUSINESSWIRE
ABOUT THIS PAGE